Mycoplasma pneumonia laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
==Laboratory Findings==
==Laboratory Findings==
Diagnosis of acute infections remains difficult; therefore, early recognition of outbreaks has been problematic. The challenge is to prevent secondary cases in outbreak by prompt initiation of control measures.


''M. pneumoniae'' infections can be differentiated from other types of pneumonia by the relatively slow progression of symptoms, a positive blood test for cold-hemagglutinins in 50-70% of patients after 10 days of infection  (cold-hemagglutinin-test should be used with caution or not at all since 50% of the tests are false-positive), lack of bacteria in a gram-stained sputum sample, and a lack of growth on blood agar.
''M. pneumoniae'' infections can be differentiated from other types of pneumonia by the relatively slow progression of symptoms, a positive blood test for cold-hemagglutinins in 50-70% of patients after 10 days of infection  (cold-hemagglutinin-test should be used with caution or not at all since 50% of the tests are false-positive), lack of bacteria in a gram-stained sputum sample, and a lack of growth on blood agar.
Line 19: Line 19:


A urine test or a throat swab may also be done.
A urine test or a throat swab may also be done.
 
==Sources==
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/mycoplasmapneum_t.htm
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
Line 25: Line 26:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category: Needs overview]]
{{WH}}
{{WS}}

Revision as of 17:23, 20 November 2012

Pneumonia Main Page

Mycoplasma pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Mycoplasma pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycoplasma pneumonia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycoplasma pneumonia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycoplasma pneumonia laboratory findings

CDC on Mycoplasma pneumonia laboratory findings

Mycoplasma pneumonia laboratory findings in the news

Blogs on Mycoplasma pneumonia laboratory findings

Directions to Hospitals Treating Mycoplasma pneumonia

Risk calculators and risk factors for Mycoplasma pneumonia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory Findings

Diagnosis of acute infections remains difficult; therefore, early recognition of outbreaks has been problematic. The challenge is to prevent secondary cases in outbreak by prompt initiation of control measures.

M. pneumoniae infections can be differentiated from other types of pneumonia by the relatively slow progression of symptoms, a positive blood test for cold-hemagglutinins in 50-70% of patients after 10 days of infection (cold-hemagglutinin-test should be used with caution or not at all since 50% of the tests are false-positive), lack of bacteria in a gram-stained sputum sample, and a lack of growth on blood agar.

Depending on the severity of illness, other tests may be done, including:

A urine test or a throat swab may also be done.

Sources

http://www.cdc.gov/ncidod/dbmd/diseaseinfo/mycoplasmapneum_t.htm

References

Template:WH Template:WS